R. Goodwin

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2

S. Steinberg, F. Marincola, S. Rosenberg, 2001, Journal of immunotherapy.

Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

N. Geller, H. Hedlin, R. Srinivasan, 2007 .

A Comparison of Apheresis Cell Content Collected from the Same Donors Mobilized with Granulocyte Colony Stimulating Factor (G-CSF) Vs. a Single Injection of AMD3100.

R. Srinivasan, A. Barrett, R. Childs, 2004 .

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

N. Geller, J. Tisdale, R. Childs, 2011, British journal of haematology.

Significant Alterations in T-Cell TH1 and TH2 Cytokine Gene Profiles Associated with G-CSF Mobilization Do Not Occur in T-Cells Mobilized with AMD3100.

N. Geller, R. Childs, A. Lundqvist, 2007 .

Chronic GVHD manifesting as parotitis after allogeneic hematopoietic SCT

N. Patronas, R. Childs, M. Ramanathan, 2009, Bone Marrow Transplantation.

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

N. Geller, J. Tisdale, R. Childs, 2011, British journal of haematology.